Tissue Net Tangible Assets from 2010 to 2025

TRX Stock   58.50  1.50  2.50%   
Tissue Regenix's Net Tangible Assets are decreasing over the years with very volatile fluctuation. Net Tangible Assets are expected to dwindle to about 17.7 M. Net Tangible Assets is the total assets of Tissue Regenix Group minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. View All Fundamentals
 
Net Tangible Assets  
First Reported
2016-04-30
Previous Quarter
15.5 M
Current Value
15.5 M
Quarterly Volatility
4.3 M
 
Covid
Check Tissue Regenix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tissue Regenix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 1 M or Selling General Administrative of 10.2 M, as well as many indicators such as . Tissue financial statements analysis is a perfect complement when working with Tissue Regenix Valuation or Volatility modules.
  
This module can also supplement various Tissue Regenix Technical models . Check out the analysis of Tissue Regenix Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Tissue Stock

Tissue Regenix financial ratios help investors to determine whether Tissue Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tissue with respect to the benefits of owning Tissue Regenix security.